
IHC-P analysis of human brain tissue using GTX85158 NALP5 antibody. Working concentration : 10 microg/ml
NALP5 antibody
GTX85158
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetNLRP5
Overview
- SupplierGeneTex
- Product NameNALP5 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1 microg/mL. IHC-P: 10 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID126206
- Target nameNLRP5
- Target descriptionNLR family pyrin domain containing 5
- Target synonymsCLR19.8, MATER, NALP5, OZEMA19, PAN11, PYPAF8, NACHT, LRR and PYD domains-containing protein 5, NACHT, leucine rich repeat and PYD containing 5, mater protein homolog, maternal antigen that embryos require, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 5
- HostRabbit
- IsotypeIgG
- Protein IDP59047
- Protein NameNACHT, LRR and PYD domains-containing protein 5
- Scientific DescriptionNALP proteins include the apoptosis regulator APAF1 (apoptotic protease activating factor 1) and mammalian NOD-LRR proteins and are thought to be involved in inflammation and reproduction. NALP5, also known as MATER, is a maternal gene required for early embryonic development in mice. Increased NALP5 expression was observed in two neuronal injury models, and transient expression of recombinant NALP5 in neurons induced caspase-3 activation and apoptosis, suggesting that NALP5 also plays a role in caspase activation and apoptosis in injured neurons, and may thus represent a novel target for therapeutic treatment in neurodegenerative disorders.
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203





